The Latest Cardiac and Vascular News
PRINCETON, N.J., Aug. 17, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced that the Israeli Ministry of Health (MoH) has approved national reimbursement for CytoSorb® in certain cardiac surgery indications that […]
– Katrin Rupalla, Ph.D., appointed Chair of Ambrx’s Board of Directors – – Ambrx to conduct strategic pipeline review with focus on commercial opportunity and cash runway extension – – Dr. Tian will continue to be available to Ambrx in an advisory capacity – SAN DIEGO–(BUSINESS WIRE)–Ambrx Biopharma Inc., or […]
Consistent evidence supports benefits of complete revascularization on LVEF, heart failure symptoms DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (Nasdaq: ABMD) announces the results of the Restore EF study demonstrate Impella-supported high-risk percutaneous coronary intervention (PCI) leads to significant improvements in left ventricular ejection fraction (LVEF), angina symptoms and heart failure symptoms at follow-up. The study, […]
HOUSTON, Aug. 16, 2022 /PRNewswire/ — Millar, Inc., a medical device manufacturer and OEM solutions partner, is pleased to announce that they have received approval from the Therapeutic Goods Administration (TGA) in Australia for their Mikro-Cath™ Pressure Catheter. The Mikro-Cath™ is a single–use pressure catheter intended to be used for medical research and diagnostic purposes. The […]
MOUNTAIN VIEW, Calif., Aug. 16, 2022 /PRNewswire/ — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced its Series F Financing led by GE Healthcare. Also joining the round are NGK-NTK (through a CVC partnership with Pegasus Tech Ventures) and existing investors including Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, […]
Submission Seeks Approval for the Company’s Proprietary ECG Technology to Aid in Diagnosis of Heart Attack in $500 million Total Addressable Market 18+ million People in the US have Coronary Artery Disease and Heart Attacks Occur Every 40 Seconds SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital […]
To provide a full spectrum of innovative solutions, the partnership aims to empower better heart care and build efficiency across the care pathway journey of the patient Unlocking the potential of interventional cardiology will be a step forward in delivering precision health BENGALURU, India, Aug. 16, 2022 /PRNewswire/ — GE Healthcare, a leading global […]
NEWTON, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the second quarter ended June 30, 2022, and provided […]
SANUWAVE Health, Inc. today announced the appointment of Dr. Toni Rinow as CFO Eden Prairie, MN, Aug. 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, today announced the appointment of Dr. Toni Rinow, MBA as Chief Financial Officer (CFO). […]
Canada is the first to benefit from the Vena BDAC™ technology developed right in the patient’s backyard for those requiring mechanical thrombectomy during ischemic stroke treatment. Kitchener, Ontario, Aug. 16, 2022 (GLOBE NEWSWIRE) — Vena Medical, a leading developer of cutting-edge neurovascular devices, announces the successful treatment of the first five […]
